Human telomerase reverse transcriptase expression in a CD34-positive hematopoietic progenitor of myelodysplastic syndrome and acute myelogenous leukemia

Hematol Oncol. 2019 Oct;37(4):520-522. doi: 10.1002/hon.2620. Epub 2019 May 30.

Authors

Hiroshi Handa¹, Natsumi Nishimoto², Madoka Inoue³, Akihiko Yokohama², Norifumi Tsukamoto⁴, Takayuki Saitoh⁵, Hirokazu Murakami⁵

Affiliations

¹ Department of Medicine, Division of Hematology, Gunma University Graduate School of Medicine, Maebashi, Japan.
² Blood Transfusion Service, Gunma University Hospital, Maebashi, Japan.
³ Department of Laboratory Medicine, Gunma University Hospital, Maebashi, Japan.
⁴ Oncology Center, Gunma University Hospital, Maebashi, Japan.
⁵ Department of Laboratory Science, Gunma University Graduate School of Health Science, Maebashi, Japan.

PMID: 30990910
DOI: 10.1002/hon.2620

No abstract available

Publication types

Letter

MeSH terms

Antigens, CD34*
Female
Gene Expression Regulation, Enzymologic*
Gene Expression Regulation, Leukemic*
Hematopoietic Stem Cells / enzymology*
Hematopoietic Stem Cells / pathology
Humans
Leukemia, Myeloid, Acute / enzymology*
Leukemia, Myeloid, Acute / genetics
Leukemia, Myeloid, Acute / pathology
Male
Myelodysplastic Syndromes / enzymology*
Myelodysplastic Syndromes / genetics
Myelodysplastic Syndromes / pathology
Neoplasm Proteins / biosynthesis*
Neoplasm Proteins / genetics
Telomerase / biosynthesis*
Telomerase / genetics

Substances

Antigens, CD34
Neoplasm Proteins
TERT protein, human
Telomerase

Grants and funding